Arthrocare Removes Spine Claims Cited By FDA From Marketing Materials
This article was originally published in The Gray Sheet
Executive Summary
Arthrocare has removed certain promotional materials and claims on its web site regarding the company's Orthopedic Electrosurgery System following a Feb. 26 warning letter from FDA.
You may also be interested in...
FDA Weighing Off-Label Concerns Posed By Internet Bibliographies
FDA is currently debating the extent to which off-label journal articles may be cited in bibliographies on device company websites.
FDA Weighing Off-Label Concerns Posed By Internet Bibliographies
FDA is currently debating the extent to which off-label journal articles may be cited in bibliographies on device company websites.
Arthrocare Eyes Nucleoplasty System To Perc Up Sales, Monitors Inamed
Arthrocare is directing Wall Street's attention to potential growth opportunities for the firm's spinal surgery business as it monitors sales of its cosmetic surgery product line by distribution partner Inamed.